Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
39.59
+0.38 (0.97%)
At close: Apr 28, 2026, 4:00 PM EDT
39.98
+0.39 (0.99%)
After-hours: Apr 28, 2026, 5:06 PM EDT
Sionna Therapeutics Market Cap
Sionna Therapeutics has a market cap or net worth of $1.79 billion as of April 28, 2026. Its market cap has increased by 428.76% in one year.
Market Cap
1.79B
Enterprise Value
1.49B
1-Year Change
428.76%
Ranking
Category
Stock Price
$39.59
Market Cap Chart
Since the IPO on February 7, 2025, Sionna Therapeutics's market cap has increased from $733.61M to $1.79B, an increase of 143.62%. That is a compound annual growth rate of 107.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.77B | -3.59% |
| Dec 31, 2025 | 1.84B | 150.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibrx Biosciences | 1.91B |
| Galapagos NV | 1.89B |
| Syndax Pharmaceuticals | 1.86B |
| Pharvaris | 1.85B |
| Palvella Therapeutics | 1.82B |
| Recursion Pharmaceuticals | 1.82B |
| Vericel | 1.81B |
| Taysha Gene Therapies | 1.79B |